Back

Hepatic t1 mapping: a new easily obtained biomarker for heart failure patients undergoing cardiac magnetic resonance.

10 May 2023 (13:19 - 13:27)
Organised by:
Congress Presentation Part of: Dechiphering the phenotypes and dynamics of cardiomyopathies under the light of multi-modality imaging T1 and T2 Mapping EACVI Premium Access EACVI 2023

About the speaker

Photo
Doctor Rita Reis Santos

Hospital Santa Cruz, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail
Tracking treatment response in cardiac AL amyloidosis with native-T1 mapping
Doctor A. Ioannou (Greater London, GB)
Abstract Slides Video
Presentation thumbnail
Prospective cascade screening for transthyretin amyloid cardiomyopathy in patients undergoing spinal stenosis surgery: results of the CASS (Cardiac Amyloidosis in Spinal Stenosis) study.
Doctor P. Debonnaire (Brugge, BE)
Abstract Slides Video
Presentation thumbnail
Dapagliflozin improves radial and longitudinal strain, increases pAMPK and reduces myocardial and renal NF-kB expression in preclinical models of doxorubicin cardiotoxicity through NLRP3 and Myd-88
Doctor N. Maurea (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Impact of myocardial inflammation on quantitative myocardial perfusion at long-term follow-up - a descriptive hybrid PET/MR myocarditis study
Professor R. Buechel (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Cardiac magnetic resonance phenotypes and cardiovascular prognosis in classical vs cardiac variant of Fabry disease
Doctor G. Guida (San Donato Milanese, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Dechiphering the phenotypes and dynamics of cardiomyopathies under the light of multi-modality imaging
Video

The Event

Event poster

EACVI 2023

10 May 2023 13:19 CET
You may be interested in
thumbnail
Congress Presentation
Liver native T1 mapping for predicting cardiovascular outcomes across stages of heart failure
thumbnail
Congress Presentation
Reduced MRI-based right-to-left ventricular blood pool T2 ratio predicts adverse events and impaired cardiopulmonary function in heart failure patients
thumbnail
Congress Session
Cardiovascular magnetic resonance: advances that can impact on clinical practice

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources